Early Pregnancy Serum Ferritin Levels as a Predictor for Gestational Diabetes Mellitus
Key facts
- Who runs it
- Zagazig University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 556 people enrolled
- Started
- 5 Dec 2022
- Ended
- 10 Oct 2025
- Type of study
- Observational, 2 groups
- Treatments tested
- Glycemic Markers
- Record updated
- 25 February 2026
Who can take part
- Age
- 21 years to 40 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Confirmed pregnancy at an early gestational age
- Provision of clinical and family history (e.g., age, BMI, history of GDM)
Who cannot take part
- Pre-existing Type 1 or Type 2 Diabetes Mellitus
- Conditions known to significantly alter iron metabolism independent of pregnancy
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective study evaluates a target population of pregnant women at the time of pregnancy diagnosis to investigate the predictive value of serum ferritin (SF) levels for the later development of gestational diabetes mellitus (GDM). The intervention involves measuring early-pregnancy SF, transferrin, and hemoglobin levels, alongside HbA1c, and comparing these biomarkers between women who later develop GDM and those who remain normoglycemic. The primary outcome is to assess the success rate of this diagnostic regimen in identifying high-risk individuals, aiming to establish SF as a valuable early biomarker for GDM to enable timely interventions.
The 2 groups in the trial
- GDM Group
Pregnant women who develop gestational diabetes mellitus later in pregnancy.
Treatment: Glycemic Markers
- Non GDM Group
Pregnant women who maintain normal glucose tolerance throughout pregnancy.
Treatment: Glycemic Markers
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- High Serum Ferritin Early in Pregnancy May Predict the Development of Gestational Diabetes Later.
- Record updated
- 25 February 2026